Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1743126 Target Snapshot

Multidrug and toxin extrusion protein 1 · SINGLE PROTEIN · Homo sapiens

79Compounds
13Assays
39Approved Drugs
95.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q96FL8. Use UniProt Q96FL8 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q96FL8 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Multidrug and toxin extrusion protein 1 as ChEMBL target CHEMBL1743126, mapped to UniProt Q96FL8. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Multidrug and toxin extrusion protein 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL1743126
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q96FL8
Multidrug and toxin extrusion protein 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Multidrug and toxin extrusion protein 1 is the right protein anchor across sources, using UniProt Q96FL8 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMultidrug and toxin extrusion protein 1
UniProt AccessionQ96FL8
Component TypeProtein
Sequence Length570 aa

Multidrug and toxin extrusion protein 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Multidrug and toxin extrusion protein 1, mapped to UniProt Q96FL8. Sequence length is 570 aa.

Mapped IDQ96FL8
Review nameMultidrug and toxin extrusion protein 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

39
Approved
7
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC5095.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL46 7.52 IC50 30.0 Approved
CHEMBL941 7.4 IC50 40.0 Approved
CHEMBL163 7.1 IC50 80.0 Approved
CHEMBL58 6.72 IC50 190.0 Approved
CHEMBL55 6.39 IC50 410.0 Approved
CHEMBL87563 6.3 IC50 500.0 Clinical
CHEMBL360861 6.19 IC50 650.0 Clinical
CHEMBL790 6.16 IC50 700.0 Approved
CHEMBL902 6.12 IC50 760.0 Approved
CHEMBL95 5.96 IC50 1100.0 Approved
Distribution

pChEMBL Value Distribution

15
5.0
24
5.5
8
6.0
3
6.5
3
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

IMATINIB
CHEMBL941
Approved 2001
RITONAVIR
CHEMBL163
Approved 1996
ONDANSETRON
CHEMBL46
Approved 1991
MITOXANTRONE
CHEMBL58
Approved 1987
FAMOTIDINE
CHEMBL902
Approved 1986
PENTAMIDINE
CHEMBL55
Approved 1984
CHLORHEXIDINE
CHEMBL790
Approved 1976
Assay Landscape

Assay Landscape

13
Total Assays
45
Tested Compounds
3
Assay Types
Binding — 8 assays, 45 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 6 44 5.6
single protein format 2 1 5.6
ADME — 4 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 3 1 5.0
cell-based format 1 7 5.1
Toxicity — 1 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 2 5.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine